EU to discuss U.S. vaccine patent plan
The Hindu
Support grows for IP waiver after U.S. decision
on Thursday in supporting an easing of patent and other protections on COVID-19 vaccines that could help poorer countries get more doses and speed the end of the pandemic. The move to support waiving intellectual property protections on vaccines under World Trade Organization rules marked a dramatic shift for the United States — and drew cheers from activists, complaints from Big Pharma, and a lot of questions about what comes next. Washington had previously lined up with many other developed nations opposed to the Attention is now turning to those richer nations, notably in the European Union — and France was the first to voice its support.More Related News